# Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor

> **NCT00406289** · PHASE1 · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 24 (estimated)

## Conditions studied

- Head and Neck Tumor

## Interventions

- **PROCEDURE:** 18F-FDG-PET radiotherapy

## Key facts

- **NCT ID:** NCT00406289
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2009-08
- **Final completion:** 2010-02
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2010-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00406289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00406289, "Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT00406289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
